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uoncurrent chemo-radiotherapy (CCRT) is the
cornerstone of treatment for patients with head
and neck cancer. However, the potential risk for
cardiovascular complications after combined ra-
diotherapy (RT) and chemotherapy is usually neglected.
RT targeting the neck region has been correlated with
intimal thickening and stenosis of the carotid arteries,
which has been shown to increase the risk for stroke (1).
In addition, chemotherapy, particularly platinum-based
regimens, has been associated with increased long-term
cardiovascular events (2). Despite the evidence linking
the potential detrimental effects of RT or chemotherapy
to vascular damage, the exact mechanism remains largely
unclear. Furthermore, most previous studies have focused
mainly on the intermediate-term or long-term effects of
RT or chemotherapy on cardiovascular events. The acute
or short-term impact of RT or chemotherapy on vascular
inflammation is currently unknown.
Recently, it has been shown that 18F-fluorode-
oxyglucose (FDG) can be taken up by macrophages
in inflammatory vascular plaque (3). Thus, vascular FDG
uptake may be an important surrogate marker for vascu-
lar inflammation (4). We hypothesized that combined
RT and chemotherapy causes localized and systemic
vascular inflammation, which ultimately leads to athero-
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2012, accepted June 26, 2012.clerosis formation and increased risk for cardiovascular
orbidities. By using serial positron emission tomo-
raphic (PET)/computed tomography (CT) hybrid
cans before and during CCRT for 1 month in patients
ith head and neck cancer, we sought to determine
hether there was increased FDG uptake over bilateral
arotid arteries or other vascular walls as a result of the
reatment and to explore the potential mechanisms of
CRT-related cardiovascular complications.
Seventeen consecutive patients with stage III to IVA
haryngeal cancer who underwent definitive cisplatin-
ased CCRT from 2009 to 2010 were enrolled in this
etrospective study (certificate number of local institu-
ional review board: DMR99-IRB-067). All of them
nderwent pre-treatment and interim PET/CT imag-
ng, scheduled during the fourth week of CCRT, with
he cumulative RT dose ranging from 36 to 45 Gy. All
atients received concurrent chemotherapy consisting of
isplatin (80 to 100 mg/m2 on days 1, 22, and 43).
maging was performed with a PET/CT scanner (Dis-
overy STE; GE Healthcare, Milwaukee, Wisconsin),
nd scanning began 60 min after intravenous injection of
70 MBq FDG. After determining the axial imaging
ange, a spiral non-contrast-enhanced low–radiation
ose CT scan was performed for anatomical reference
nd attenuation correction. PET emission images were
hen acquired serially after CT scans at 2 min per field of
iew in 3-dimensional acquisition mode with a 1-slice
verlap at the borders of the field of view.
Vendor-provided software (Xeleris, GE Health-
are) was used for processing and analysis of the
ET/CT images. Vascular inflammation was as-
essed visually on the transaxial, coronal, and sagittal
lanes and was defined as increased FDG radioactivity
long the vascular wall compared with the corresponding
natomical features on the CT component of PET/CT
maging. A spherical volume of interest with a diameter
f 5 mm generated by the vendor-provided software was
sed for measuring the maximum standardized uptake
alue (SUVmax) of the vascular wall. Background blood-
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513pool activity was calculated by averaging the representa-
tive SUVmax of the superior and inferior vena cavae.
Then, the target-to-background ratio (TBR), which
represents corrected vascular to background blood-pool
radioactivity (5) was calculated by dividing the represen-
tative SUVmax of analyzed vascular segment with the
background blood-pool radioactivity.
Demographic data showed that our study sub-
jects were essentially low–cardiovascular risk pa-
tients before CCRT (Online Table 1). FDG uptake
values, reported as SUVmax and TBR, before and 1
month after CCRT are shown in Table 1. Com-
pared with the data before CCRT, significantly
increased TBR values 1 month after CCRT were
noted in the right (p  0.001) and left (p  0.002)
carotid arteries (Fig. 1). Furthermore, the increased
arterial FDG uptake was not confined to the
bilateral carotid arteries. Vessels other than the carotid
arteries also showed significantly increased TBR val-
ues after CCRT (Online Fig. 1), including the as-
cending aorta (p  0.001), aortic arch (p  0.006),
pper thoracic descending aorta (p 0.001), midtho-
racic descending aorta (p  0.001), lower thoracic
descending aorta (p  0.001), and abdominal aorta
(p  0.001). Even at more remote sites from the
irradiation target, such as the right and left iliac arteries,
the TBR values also significantly increased after CCRT
(p  0.004 and p  0.002, respectively). The SUVmax
values after CCRT also showed a similar incremental
pattern over multiple vascular segments (Table 1).
Using PET/CT imaging to evaluate vascular FDG
ptakes before and after CCRT, we observed a gen-
ral increase in vascular FDG uptake after treatment.
ur findings suggest that cisplatin-based CCRT can
rigger systemic vascular inflammation in a short
eriod of time, which may ultimately progress to
Table 1. Vascular FDG Uptake on PET/CT Imaging Before and D
S
Location Before CCRT D
Right carotid artery 1.424
Left carotid artery 1.477
Ascending aorta 2.018
Aortic arch 2.061
Upper thoracic descending aorta 1.903
Midthoracic descending aorta 1.856
Lower thoracic descending aorta 1.871
Abdominal aorta 1.871
Right iliac artery 1.499
Left iliac artery 1.582
TBR values are mean  SD. The Wilcoxon signed-rank test was used to determi
CCRT  concurrent chemo-radiotherapy; CT  computed tomography; FDG TBR  target-to-background ratio.ascular atherosclerotic formation later in life. To the
est of our knowledge, this is the first study using serial
ET/CT scans as a tool to evaluate the short-term effects
f CCRT on vascular inflammation.
Although we have undertaken a pilot study using
erial PET/CT scans as a novel tool to detect CCRT-
nduced vascular inflammation, there were several
imitations to this study. First, it was a single-center,
etrospective study with a small sample size; the results
eed to be confirmed in large-scale studies. Second,
lthough we identified acute vascular inflammation
uring CCRT, the chronic effect is still unclear in this
atient population. Finally, because both RT and
hemotherapy may contribute to the vascular inflam-
ation in this study, the RT-specific or cisplatin-
pecific effects on the post-treatment vascular FDG
ptake change remain to be elucidated. We believe
hat further large-scale prospective studies with long-
erm follow-up are necessary to clarify these questions.
In conclusion, serial PET/CT examinations show
ncreased systemic vascular FDG uptake after cisplatin-
ased CCRT in patients with head and neck cancer.
hese preliminary results suggest that the increased
therothrombotic event rate seen after CCRT may be
elated to vascular inflammation induced by CCRT, and
ET/CT imaging could be used to identify effective
reatment options that may reduce and/or prevent
CRT-induced vascular inflammation in these patients.
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g CCRT
ax TBR
g CCRT p Value Before CCRT During CC
.563 0.037 0.7 0.1 0.9 0.
.601 0.029 0.8 0.1 1.0 0.
.260 0.006 1.1 0.1 1.3 0.
.152 0.298 1.1 0.2 1.3 0.
.130 0.009 1.0 0.1 1.2 0.
.035 0.097 1.0 0.2 1.2 0.
.021 0.031 1.0 0.2 1.2 0.
.022 0.033 1.0 0.2 1.2 0.
.612 0.256 0.8 0.1 0.9 0.
.693 0.124 0.8 0.1 1.0 0.
e statistical differences of FDG uptake values between serial PET/CT examinations
-ﬂuorodeoxyglucose; PET  positron emission tomography; SUVmax  maximal surin
UVm
urin RT p Value
1 2 0.001
1 2 0.002
2 3 0.001
2 4 0.006
2 2 0.001
2 3 0.001
2 3 0.001
2 3 0.001
1 2 0.004
1 1 0.002
ne th before and during CCRT.
18F tandardized uptake value;
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